Insulin-like growth factor-1 increases the mitogenic response of human peripheral blood lymphocytes to phytohemagglutinin

Immunol Lett. 1989 Jan 15;20(1):5-8. doi: 10.1016/0165-2478(89)90060-6.

Abstract

Receptors for insulin and insulin-like growth factor-1 (IGF-1) have been demonstrated on activated T-lymphocytes. The question is whether receptors for insulin or IGF-1 have any function in these cells. In this study we demonstrate that the concentration of IGF-1 in commercial samples of fetal calf serum is about 70 times that of insulin. Moreover, antibodies binding IGF-1 reduce responses of human peripheral blood mononuclear cells to PHA by about 50%, whereas antibodies to insulin have no demonstrable effect. These observations suggest that binding of IGF-1 to specific receptors contributes to the proliferative responses of activated T-lymphocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / immunology
  • Cattle / blood
  • Cell Division / drug effects
  • Fetal Blood / physiology
  • Humans
  • Insulin-Like Growth Factor I / immunology
  • Insulin-Like Growth Factor I / isolation & purification
  • Insulin-Like Growth Factor I / pharmacology*
  • Lymphocyte Activation / drug effects*
  • Phytohemagglutinins / pharmacology*
  • Receptors, Cell Surface / physiology
  • Receptors, Somatomedin
  • Recombinant Proteins / pharmacology
  • Somatomedins / pharmacology*
  • Stimulation, Chemical
  • T-Lymphocytes / cytology
  • T-Lymphocytes / drug effects*

Substances

  • Antibodies
  • Phytohemagglutinins
  • Receptors, Cell Surface
  • Receptors, Somatomedin
  • Recombinant Proteins
  • Somatomedins
  • Insulin-Like Growth Factor I